CVS Health Corporation (CVS)

CVS Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	119,776	100,742	56,490	101,613	122,449	136,274
Market Cap Growth	37.66%	78.34%	-44.41%	-17.02%	-10.15%	52.43%
Enterprise Value	182,124	171,444	129,676	165,694	173,860	202,401
Last Close Price	93.65	77.55	42.07	71.02	81.20	87.90

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	24.54	56.98	12.24	12.18	28.40	17.03
Forward PE	11.49	11.54	7.77	9.39	10.67	12.88
PS Ratio	0.29	0.25	0.15	0.28	0.38	0.47
PB Ratio	1.50	1.34	0.75	1.33	1.71	1.81
P/FCF Ratio	10.19	12.90	8.93	9.78	9.10	8.65
P/OCF Ratio	8.10	9.47	6.20	7.57	7.57	7.46
PEG Ratio	1.09	0.76	0.61	1.92	2.05	2.15

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	0.44	0.43	0.35	0.47	0.54	0.70
EV/EBITDA Ratio	10.92	11.72	10.28	8.99	8.71	10.86
EV/EBIT Ratio	14.98	17.11	16.17	11.77	11.04	14.30
EV/FCF Ratio	15.49	21.96	20.50	15.94	12.93	12.86

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.96	1.06	1.10	1.04	0.99	1.01
Debt / EBITDA Ratio	3.87	4.53	5.30	3.68	3.06	3.48
Debt / FCF Ratio	6.49	10.24	13.11	7.64	5.26	4.83
Net Debt / Equity Ratio	0.78	0.92	0.95	0.89	0.77	0.84
Net Debt / EBITDA Ratio	3.74	4.74	5.70	3.68	2.76	3.41
Net Debt / FCF Ratio	5.30	8.88	11.37	6.54	4.09	4.03
Asset Turnover	1.61	1.58	1.47	1.49	1.40	1.25
Inventory Turnover	20.32	18.56	17.79	16.35	14.54	13.24
Quick Ratio	0.62	0.57	0.56	0.59	0.62	0.55
Current Ratio	0.87	0.84	0.81	0.86	0.95	0.89
Return on Equity (ROE)	6.21%	2.29%	6.02%	11.28%	5.88%	11.01%
Return on Assets (ROA)	2.97%	2.47%	1.99%	3.68%	4.27%	3.82%
Return on Invested Capital (ROIC)	7.17%	5.54%	4.09%	7.77%	8.79%	7.59%
Return on Capital Employed (ROCE)	7.30%	6.10%	4.80%	8.30%	9.90%	8.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	4.08%	1.75%	8.17%	8.21%	3.52%	5.87%
FCF Yield	9.82%	7.75%	11.20%	10.23%	10.98%	11.55%
Dividend Yield	2.84%	3.43%	6.32%	3.41%	2.71%	2.27%
Payout Ratio	69.70%	192.14%	73.10%	37.54%	67.43%	32.81%
Buyback Yield / Dilution	-1.19%	-0.71%	2.17%	2.49%	0.45%	-1.14%
Total Shareholder Return	1.65%	2.72%	8.49%	5.90%	3.16%	1.13%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error